{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:40:03Z","timestamp":1789926003933,"version":"4.0.1"},"reference-count":260,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatorenal syndrome (HRS) is a disorder associated with cirrhosis and renal impairment, with portal hypertension as its major underlying cause. Moreover, HRS is the third most common cause of acute kidney injury, thus creating a major public health concern. This review summarizes the available information on the pathophysiological implications of HRS. We discuss pathogenesis associated with HRS. Mechanisms such as dysfunction of the circulatory system, bacterial infection, inflammation, impaired renal autoregulation, circulatory, and others, which have been identified as critical pathways for development of HRS, have become easier to diagnose in recent years. Additionally, relatively recently, renal dysfunction biomarkers have been found indicating renal injury, which are involved in the pathophysiology of HRS. This review also summarizes the available information on the management of HRS, focusing on vasoconstrictive drugs, renal replacement therapy, and liver transplant together with currently being investigated novel therapies. Analyzing new discoveries for the underlying causes of this condition assists the general research to improve understanding of the mechanism of pathophysiology and thus prevention of HRS.<\/jats:p>","DOI":"10.3390\/ijms242417469","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T03:16:33Z","timestamp":1702610193000},"page":"17469","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hepatorenal Syndrome\u2014Novel Insights into Diagnostics and Treatment"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6233-8882","authenticated-orcid":false,"given":"Krzysztof","family":"Badura","sequence":"first","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3620-3120","authenticated-orcid":false,"given":"Weronika","family":"Fr\u0105k","sequence":"additional","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6892-6199","authenticated-orcid":false,"given":"Joanna","family":"Hajdys","sequence":"additional","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0447-8510","authenticated-orcid":false,"given":"Gabriela","family":"Majchrowicz","sequence":"additional","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6799-4746","authenticated-orcid":false,"given":"Ewelina","family":"M\u0142ynarska","sequence":"additional","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Rysz","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Franczyk","sequence":"additional","affiliation":[{"name":"Department of Nephrocardiology, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis\u2014Aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.14309\/ajg.0000000000001909","article-title":"Comorbid Chronic Diseases and Survival in Compensated and Decompensated Cirrhosis: A Population-Based Study","volume":"117","author":"Asrani","year":"2022","journal-title":"Am. J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cld.2022.01.013","article-title":"Hepatorenal Syndrome","volume":"26","author":"Csak","year":"2022","journal-title":"Clin. Liver. Dis."},{"key":"ref_4","first-page":"e43073","article-title":"A Comprehensive Systematic Review of the Latest Management Strategies for Hepatorenal Syndrome: A Complicated Syndrome to Tackle","volume":"15","author":"Roy","year":"2023","journal-title":"Cureus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000375344","article-title":"Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis","volume":"33","year":"2015","journal-title":"Dig. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4254\/wjh.v9.i6.293","article-title":"Hepatorenal syndrome: Update on diagnosis and therapy","volume":"9","author":"Acevedo","year":"2017","journal-title":"World J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.jhep.2023.07.010","article-title":"Incidence outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the, US","volume":"79","author":"Patidar","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0032-1301735","article-title":"Hepatorenal Syndrome: A Critical Update","volume":"33","author":"Wadei","year":"2012","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Escorsell","year":"1993","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1590\/s0004-2803.202202000-48","article-title":"Cost effectiveness of using terlipressin to treat hepatorenal syndrome","volume":"59","author":"Ferreira","year":"2022","journal-title":"Arq. Gastroenterol."},{"key":"ref_11","first-page":"227","article-title":"Hepatorenal syndrome: Pathophysiology and evidence-based management update","volume":"59","author":"Hasan","year":"2021","journal-title":"Rom. J. Intern. Med."},{"key":"ref_12","unstructured":"Ranasinghe, I.R., Sharma, B., and Bashir, K. (2023). StatPearls [Internet], StatPearls Publishing."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.15403\/jgld-4618","article-title":"Outcomes, Mortality, and Cost Burden of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis","volume":"32","author":"Patel","year":"2023","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.3748\/wjg.v27.i26.3984","article-title":"Acute kidney injury and hepatorenal syndrome in cirrhosis","volume":"27","author":"Gupta","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cgh.2023.04.034","article-title":"Pathophysiology of Hepatorenal Syndrome\u2013Acute Kidney Injury","volume":"21","author":"Adebayo","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.cgh.2023.06.006","article-title":"Current Pharmacologic Therapies for Hepatorenal Syndrome-Acute Kidney Injury","volume":"21","author":"Duong","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"m2687","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: Pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41581-019-0218-4","article-title":"Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis","volume":"16","author":"Velez","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/liv.14037","article-title":"Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival","volume":"39","author":"Huelin","year":"2019","journal-title":"Liver Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","article-title":"The spectrum of renal lesions in patients with cirrhosis: A clinicopathological study","volume":"30","author":"Paradis","year":"2010","journal-title":"Liver Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.ajkd.2011.12.032","article-title":"Hepatorenal Syndrome: A Severe, but Treatable, Cause of Kidney Failure in Cirrhosis","volume":"59","author":"Fagundes","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9343(70)80073-0","article-title":"Renal failure in the patient with cirrhosis","volume":"49","author":"Epstein","year":"1970","journal-title":"Am. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal Failure in Cirrhosis","volume":"361","author":"Schrier","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2215\/CJN.12451018","article-title":"Hepatorenal Syndrome","volume":"14","author":"Francoz","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.ajkd.2015.09.013","article-title":"Pathogenesis of Hepatorenal Syndrome: Implications for Therapy","volume":"67","author":"Durand","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Monescillo","year":"2005","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric Oxide as a Mediator of Hemodynamic Abnormalities and Sodium and Water Retention in Cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The Hyperdynamic Circulation of Chronic Liver Diseases: From the Patient to the Molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/gast.2002.30305","article-title":"Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat","volume":"122","author":"Ros","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic Importance of the Cause of Renal Failure in Patients with Cirrhosis","volume":"140","author":"Guevara","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrgastro.2013.210","article-title":"Cirrhotic cardiomyopathy: Pathogenesis and clinical relevance","volume":"11","author":"Wiese","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12072-008-9109-7","article-title":"Cirrhotic cardiomyopathy","volume":"3","author":"Wong","year":"2009","journal-title":"Hepatol. Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0168-8278(98)80022-6","article-title":"The sympathetic nervous system in liver disease","volume":"29","author":"Henriksen","year":"1998","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-1007295","article-title":"Hepatorenal Disorders: Role of the Renin-Angiotensin-Aldosterone System","volume":"14","author":"Bernardi","year":"1994","journal-title":"Semin. Liver. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.2006.107789","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"84","author":"Salerno","year":"2008","journal-title":"Postgrad. Med. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2010.08.001","article-title":"Renal and circulatory dysfunction in cirrhosis: Current management and future perspectives","volume":"53","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_41","first-page":"1408","article-title":"The role of duplex-doppler ultrasonography in the diagnosis of renal dysfunction and hepatorenal syndrome in patients with liver cirrhosis","volume":"51","author":"Kastelan","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/hep.29915","article-title":"Disruption of Renal Arginine Metabolism Promotes Kidney Injury in Hepatorenal Syndrome in Mice","volume":"68","author":"Varga","year":"2018","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9343(86)90912-5","article-title":"Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites: An overview with emphasis on pathogenesis","volume":"81","author":"Arroyo","year":"1986","journal-title":"Am. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2015.04.004","article-title":"Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study","volume":"63","author":"Elia","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","article-title":"Hepatorenal Syndrome: Pathophysiology and Management","volume":"1","author":"Wadei","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship Between Activation of the Sympathetic Nervous System and Renal Blood Flow Autoregulation in Cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.21920","article-title":"Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure","volume":"46","author":"Thabut","year":"2007","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2009.04.017","article-title":"The systemic inflammatory response syndrome in cirrhotic patients: Relationship with their in-hospital outcome","volume":"51","author":"Cazzaniga","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2011.12.030","article-title":"C-Reactive protein predicts short-term mortality in patients with cirrhosis","volume":"56","author":"Cervoni","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2014.03.014","article-title":"Inflammation and portal hypertension\u2013The undiscovered country","volume":"61","author":"Mehta","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jhep.2013.01.038","article-title":"Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function","volume":"58","author":"Vanheel","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/liv.14057","article-title":"Systemic inflammation in hepatorenal syndrome\u2014A target for novel treatment strategies?","volume":"39","author":"Lange","year":"2019","journal-title":"Liver Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/hep.26687","article-title":"Type-1 hepatorenal syndrome associated with infections in cirrhosis: Natural history, outcome of kidney function, and survival","volume":"59","author":"Barreto","year":"2014","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal Failure in Patients with Cirrhosis and Sepsis Unrelated to Spontaneous Bacterial Peritonitis: Value of MELD Score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2011.11.023","article-title":"Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study","volume":"56","author":"Pereira","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000064280","article-title":"Inflammatory Cytokines and Lipopolysaccharide Induce Fas-Mediated Apoptosis in Renal Tubular Cells","volume":"91","author":"Jo","year":"2002","journal-title":"Nephron"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure","volume":"64","author":"Stauber","year":"2016","journal-title":"Hepatology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.3748\/wjg.v25.i28.3684","article-title":"Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand?","volume":"25","author":"Chancharoenthana","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","article-title":"Liver\u2014Guardian, modifier and target of sepsis","volume":"14","author":"Strnad","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"32341","DOI":"10.1038\/srep32341","article-title":"Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis","volume":"6","author":"Huelin","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/liv.13893","article-title":"Hepatorenal syndrome in the era of acute kidney injury","volume":"38","author":"Pose","year":"2018","journal-title":"Liver Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/liv.12047","article-title":"Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis","volume":"33","author":"Shah","year":"2013","journal-title":"Liver Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1053\/jhep.2003.50304","article-title":"Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00042737-200406000-00010","article-title":"Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"16","author":"Such","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","article-title":"Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression","volume":"56","author":"Shah","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/hep.510280510","article-title":"Reduction of renal cortical blood flow assessed by doppler in cirrhotic patients with refractory ascites","volume":"28","author":"Rivolta","year":"1998","journal-title":"Hepatology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1159\/000363584","article-title":"A Pilot Study to Evaluate Renal Hemodynamics in Cirrhosis by Simultaneous Glomerular Filtration Rate, Renal Plasma Flow, Renal Resistive Indices and Biomarkers Measurements","volume":"39","author":"Mindikoglu","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","article-title":"A Unified Theory of Sepsis-Induced Acute Kidney Injury: Inflammation, microcirculatory dysfunction, bioenergetics and the tubular cell adaptation to injury","volume":"41","author":"Gomez","year":"2014","journal-title":"Shock"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/apt.12891","article-title":"Relative adrenal insufficiency in chronic liver disease: Its prevalence and effects on long-term mortality","volume":"40","author":"Jang","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.dld.2018.05.011","article-title":"Relative adrenal insufficiency in cirrhotic patients with ascites (hepatoadrenal syndrome)","volume":"50","author":"Singh","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cgh.2019.09.035","article-title":"Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure","volume":"18","author":"Piano","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.4254\/wjh.v7.i8.1112","article-title":"Adrenal insufficiency in patients with decompensated cirrhosis","volume":"7","author":"Karagiannis","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.26535","article-title":"Relative adrenal insufficiency in decompensated cirrhosis: Relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death","volume":"58","author":"Acevedo","year":"2013","journal-title":"Hepatology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/hep.21101","article-title":"Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock","volume":"43","author":"Tsai","year":"2006","journal-title":"Hepatology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10620-017-4471-8","article-title":"Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis","volume":"62","author":"Kim","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.aohep.2019.06.022","article-title":"Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerations","volume":"19","year":"2020","journal-title":"Ann. Hepatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2354253","DOI":"10.1155\/2017\/2354253","article-title":"Evaluation of Adrenal Function in Nonhospitalized Patients with Cirrhosis","volume":"2017","author":"Moini","year":"2017","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00134-005-0005-5","article-title":"Adrenal-exhaustion syndrome in patients with liver disease","volume":"32","author":"Marik","year":"2006","journal-title":"Intensive Care Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1056\/NEJMra0804635","article-title":"Predisposing Factors for Adrenal Insufficiency","volume":"360","author":"Bornstein","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/hep.30499","article-title":"Cholemic Nephropathy Causes Acute Kidney Injury and Is Accompanied by Loss of Aquaporin 2 in Collecting Ducts","volume":"69","author":"Mederacke","year":"2019","journal-title":"Hepatology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ki.2013.78","article-title":"Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction","volume":"84","author":"Salem","year":"2013","journal-title":"Kidney Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/hep.26599","article-title":"Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice","volume":"58","author":"Fickert","year":"2013","journal-title":"Hepatology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc6765","article-title":"Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: A prospective uncontrolled trial","volume":"12","author":"Umgelter","year":"2008","journal-title":"Crit. Care"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000501299","article-title":"Point-of-Care Echocardiography Unveils Misclassification of Acute Kidney Injury as Hepatorenal Syndrome","volume":"50","author":"Velez","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"ref_93","first-page":"2523","article-title":"Hepatorenal syndrome: Insights into the mechanisms of intra-abdominal hypertension","volume":"6","author":"Chang","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00000658-198211000-00015","article-title":"Elevated Intra-abdominal Pressure and Renal Function","volume":"196","author":"Harman","year":"1982","journal-title":"Ann. Surg."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archsurg.133.1.39","article-title":"High Intra-abdominal Pressure Increases Plasma Catecholamine Concentrations during Pneumoperitoneum for Laparoscopic Procedures","volume":"133","author":"Mikami","year":"1998","journal-title":"Arch. Surg."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00007611-199804000-00002","article-title":"Abdominal Compartment Syndrome","volume":"91","author":"Watson","year":"1998","journal-title":"South. Med. J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9343(87)90442-6","article-title":"Hepatorenal syndrome. Studies of the effect of vascular volume and intraperitoneal pressure on renal and hepatic function","volume":"82","author":"Cade","year":"1987","journal-title":"Am. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00134-008-1253-y","article-title":"Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites","volume":"35","author":"Umgelter","year":"2009","journal-title":"Intensive Care Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.1840140403","article-title":"Hepatorenal reflex regulating kidney function","volume":"14","author":"Lang","year":"1991","journal-title":"Hepatology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/ki.2010.4","article-title":"Afferent mechanisms of sodium retention in cirrhosis and hepatorenal syndrome","volume":"77","author":"Oliver","year":"2010","journal-title":"Kidney Int."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/jhep.2002.30425","article-title":"Decreases in portal flow trigger a hepatorenal reflex to inhibit renal sodium and water excretion in rats: Role of adenosine","volume":"35","author":"Ming","year":"2002","journal-title":"Hepatology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1139\/y06-063","article-title":"Intrahepatic adenosine-mediated activation of hepatorenal reflex is via A1 receptors in rats","volume":"84","author":"Ming","year":"2006","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","article-title":"Clinical Application of Kidney Biomarkers in Cirrhosis","volume":"76","author":"Allegretti","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO Clinical Practice Guidelines for Acute Kidney Injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin. Pract."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ajcn\/37.3.478","article-title":"Measurement of muscle mass in humans: Validity of the 24-hour urinary creatinine method","volume":"37","author":"Heymsfield","year":"1983","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13539-012-0079-1","article-title":"Serum creatinine as a marker of muscle mass in chronic kidney disease: Results of a cross-sectional study and review of literature","volume":"4","author":"Patel","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.jhep.2021.01.025","article-title":"Sarcopenia and frailty in decompensated cirrhosis","volume":"75","author":"Tandon","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archinte.1994.00420020117013","article-title":"Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis","volume":"154","author":"Caregaro","year":"1994","journal-title":"Arch. Intern Med."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Laszczy\u0144ska, O., Azevedo, A., Ferreira-Almeida, M., Guimar\u00e3es, J.T., and Severo, M. (2020). Conversion methods for modified Jaffe reaction assays of serum creatinine. Porto Biomed. J., 5.","DOI":"10.1097\/j.pbj.0000000000000072"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.clinbiochem.2015.10.015","article-title":"Evaluation of bilirubin interference and accuracy of six creatinine assays compared with isotope dilution\u2013liquid chromatography mass spectrometry","volume":"49","author":"Nah","year":"2016","journal-title":"Clin. Biochem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/ckj\/sfab042","article-title":"Assessment of kidney function: Clinical indications for measured, GFR","volume":"14","author":"Ebert","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MNH.0000000000000115","article-title":"Cystatin C as a biomarker for estimating glomerular filtration rate","volume":"24","author":"Ferguson","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3350\/kjhep.2010.16.3.301","article-title":"Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis","volume":"16","author":"Chung","year":"2010","journal-title":"Korean J. Hepatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.26886","article-title":"Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis","volume":"59","author":"Dolomanova","year":"2014","journal-title":"Hepatology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/003655102753611753","article-title":"Plasma cystatin C as a marker of renal function in patients with liver cirrhosis","volume":"62","author":"Randers","year":"2002","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.ajkd.2021.04.016","article-title":"Measurement and Estimation of GFR for Use in Clinical Practice: Core Curriculum 2021","volume":"78","author":"Inker","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2215\/CJN.12791019","article-title":"Kidney Disease, Race, and GFR Estimation","volume":"15","author":"Levey","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Wei, L., Ye, X., Pei, X., Wu, J., and Zhao, W. (2014). Reference Intervals for Serum Cystatin C and Factors Influencing Cystatin C Levels Other than Renal Function in the Elderly. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086066"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"766516","DOI":"10.3389\/fendo.2021.766516","article-title":"Association Between Serum Cystatin C and Thyroid Diseases: A Systematic Review and Meta-Analysis","volume":"12","author":"Xin","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1046\/j.1523-1755.2003.00925.x","article-title":"Impact of thyroid dysfunction on serum cystatin C","volume":"63","author":"Fricker","year":"2003","journal-title":"Kidney Int."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jceh.2021.09.019","article-title":"Fractional Excretion of Sodium and Urea in Differentiating Acute Kidney Injury Phenotypes in Decompensated Cirrhosis","volume":"12","author":"Gowda","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/apha.12764","article-title":"Biomarkers in acute kidney injury\u2013pathophysiological basis and clinical performance","volume":"219","author":"Schrezenmeier","year":"2017","journal-title":"Acta Physiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"376795","DOI":"10.1155\/2014\/376795","article-title":"Urinary Biomarkers of Acute Kidney Injury in Patients with Liver Cirrhosis","volume":"2014","author":"Qasem","year":"2014","journal-title":"ISRN Nephrol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00467-012-2285-7","article-title":"Impact of sepsis on the urinary level of interleukin-18 and cystatin C in critically ill neonates","volume":"28","author":"Li","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.ajkd.2013.05.014","article-title":"Urinary Interleukin 18 for Detection of Acute Kidney Injury: A Meta-analysis. Am","volume":"62","author":"Liu","year":"2013","journal-title":"J. Kidney Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/SHK.0b013e318240bdc8","article-title":"Protective Effects of Exogenous Interleukin 18\u2013Binding Protein in a Rat Model of Acute Renal Ischemia-Reperfusion Injury","volume":"37","author":"Wang","year":"2012","journal-title":"Shock"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.dld.2016.11.001","article-title":"Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis","volume":"49","author":"Yap","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.ki.5002165","article-title":"Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage","volume":"71","author":"Mori","year":"2007","journal-title":"Kidney Int."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Mortality and Identifies Acute Kidney Injury in Cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Ariza, X., Sol\u00e0, E., Elia, C., Barreto, R., Moreira, R., Morales-Ruiz, M., Graupera, I., Rodr\u00edguez, E., Huelin, P., and Sol\u00e9, C. (2015). Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128145"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/FTD.0000000000000589","article-title":"Biomarkers of Drug-Induced Kidney Toxicity","volume":"41","author":"Griffin","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"George, B., Szilagyi, J.T., Joy, M.S., and Aleksunes, L.M. (2022). Regulation of renal calbindin expression during cisplatin-induced kidney injury. J. Biochem. Mol. Toxicol., 36.","DOI":"10.1002\/jbt.23068"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s002400000158","article-title":"Isoenzyme profile of glutathione S-transferases in human kidney","volume":"29","author":"Simic","year":"2001","journal-title":"Urol. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"26335","DOI":"10.1038\/srep26335","article-title":"Urinary \u03c0-glutathione S-transferase Predicts Advanced Acute Kidney Injury Following Cardiovascular Surgery","volume":"6","author":"Shu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/bj2860383","article-title":"Purification and characterization of eight glutathione S-transferase isoenzymes of hamster. Comparison of subunit composition of enzymes from liver, kidney, testis, pancreas and trachea","volume":"286","author":"Bogaards","year":"1992","journal-title":"Biochem. J."},{"key":"ref_138","first-page":"42","article-title":"Activity of glutathione S-transferases in the urine of kidney transplant recipients during the first week after transplantation","volume":"4","author":"Polak","year":"1999","journal-title":"Ann. Transplant."},{"key":"ref_139","first-page":"204","article-title":"Urinary glutathione S-transferase as an early marker for renal dysfunction in patients admitted to intensive care with sepsis","volume":"11","author":"Walshe","year":"2009","journal-title":"Crit. Care Resusc."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00011-018-1200-5","article-title":"The role of osteopontin in kidney diseases","volume":"68","author":"Kaleta","year":"2019","journal-title":"Inflamm. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11255-020-02417-x","article-title":"Plasma osteopontin levels in patients with acute kidney injury requiring dialysis: A study in a tertiary care institute in South India","volume":"52","author":"Varalakshmi","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/lt.26344","article-title":"Role of Novel Kidney Biomarkers in Patients with Cirrhosis and After Liver Transplantation","volume":"28","author":"Asrani","year":"2022","journal-title":"Liver Transplant."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ndt\/gfq498","article-title":"Osteopontin predicts survival in critically ill patients with acute kidney injury","volume":"26","author":"Lorenzen","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MNH.0000000000000186","article-title":"Monocyte chemoattractant protein-1 and the kidney","volume":"25","author":"Haller","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_145","first-page":"198","article-title":"Renal monocyte chemoattractant protein-1: An emerging universal biomarker and therapeutic target for kidney diseases? Nephrol","volume":"35","author":"Tam","year":"2019","journal-title":"Dial. Transplant."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.2014.338","article-title":"Renal dysfunction in cirrhosis is not just a vasomotor nephropathy","volume":"87","author":"Adebayo","year":"2015","journal-title":"Kidney Int."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/1354750X.2019.1652347","article-title":"Urinary cell cycle arrest biomarker [TIMP-2]\u00b7[IGFBP7] in patients with hepatorenal syndrome","volume":"24","author":"Zhang","year":"2019","journal-title":"Biomarkers"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Carstens, J., Gr\u00f8nb\u00e6k, H., Larsen, H.K., Pedersen, E.B., and Vilstrup, H. (2007). Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention. BMC Gastroenterol., 7.","DOI":"10.1186\/1471-230X-7-1"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2362.1990.tb01800.x","article-title":"Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance","volume":"20","author":"Angeli","year":"1990","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: Epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.amjcard.2019.10.029","article-title":"Safety of Sodium-Glucose Co-Transporter 2 Inhibitors","volume":"124","author":"McGill","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4254\/wjh.v8.i34.1497","article-title":"Fractional excretion of sodium in hepatorenal syndrome: Clinical and pathological correlation","volume":"8","author":"Alsaad","year":"2016","journal-title":"World J. Hepatol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archinte.1985.00360010144022","article-title":"Fractional excretion of sodium. Exceptions to its diagnostic value","volume":"145","author":"Zarich","year":"1985","journal-title":"Arch. Intern. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.pop.2020.08.008","article-title":"Acute Kidney Injury","volume":"47","author":"Jacob","year":"2020","journal-title":"Prim. Care Clin. Off. Pract."},{"key":"ref_156","first-page":"631","article-title":"Acute kidney injury: A guide to diagnosis and management","volume":"86","author":"Rahman","year":"2012","journal-title":"Am. Fam. Physician"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-018-09923-2","article-title":"Chinese guidelines on the management of ascites and its related complications in cirrhosis","volume":"13","author":"Xu","year":"2019","journal-title":"Hepatol. Int."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/hep.29303","article-title":"Significance of oliguria in critically ill patients with chronic liver disease","volume":"66","author":"Amathieu","year":"2017","journal-title":"Hepatology"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","article-title":"New Consensus Definition of Acute Kidney Injury Accurately Predicts 30-Day Mortality in Patients With Cirrhosis and Infection","volume":"145","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/lt.24794","article-title":"Beta-blockers in patients with advanced liver disease: Has the dust settled?","volume":"23","author":"Kalainy","year":"2017","journal-title":"Liver Transplant."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"175628482211026","DOI":"10.1177\/17562848221102679","article-title":"Management of hepatorenal syndrome in liver cirrhosis: A recent update","volume":"15","author":"Bera","year":"2022","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ajg.2017.122","article-title":"Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes","volume":"112","author":"Wong","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.ajkd.2011.07.017","article-title":"Therapeutic Response to Vasoconstrictors in Hepatorenal Syndrome Parallels Increase in Mean Arterial Pressure: A Pooled Analysis of Clinical Trials","volume":"58","author":"Velez","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JEP.S146034","article-title":"In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2","volume":"10","author":"Jamil","year":"2017","journal-title":"J. Exp. Pharmacol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1172\/JCI200419656","article-title":"The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions","volume":"113","author":"Tanoue","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0168-8278(14)61096-5","article-title":"Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis","volume":"60","author":"Elia","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cgh.2016.07.016","article-title":"Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients with Systemic Inflammatory Response Syndrome","volume":"15","author":"Wong","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.cgh.2022.08.033","article-title":"AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients with Cirrhosis: Expert Review","volume":"20","author":"Flamm","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An Open Label, Pilot, Randomized Controlled Trial of Noradrenaline Versus Terlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.30208","article-title":"Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure","volume":"71","author":"Arora","year":"2020","journal-title":"Hepatology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000199224","article-title":"Effect of Somatostatin on Splanchnic Hemodynamics in Patients with Liver Cirrhosis and Portal Hypertension","volume":"32","author":"Merkel","year":"1985","journal-title":"Digestion"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/MEG.0000000000001700","article-title":"Standardized approach of albumin, midodrine and octreotide on hepatorenal syndrome treatment response rate","volume":"33","author":"Hiruy","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ncpgasthep0680","article-title":"Drug Insight: The role of albumin in the management of chronic liver disease","volume":"4","author":"Wong","year":"2007","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","article-title":"Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: Molecular mechanisms","volume":"57","author":"Bortoluzzi","year":"2013","journal-title":"Hepatology"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1073\/pnas.84.16.5918","article-title":"Antioxidant activity of albumin-bound bilirubin","volume":"84","author":"Stocker","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1164\/ajrccm.162.4.9910106","article-title":"Albumin-mediated Regulation of Cellular Glutathione and Nuclear Factor Kappa B Activation","volume":"162","author":"Cantin","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0008-6363(02)00492-3","article-title":"Albumin selectively inhibits TNF\u03b1-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells","volume":"55","author":"Zhang","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Monteagudo","year":"2005","journal-title":"Hepatology"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/apt.14052","article-title":"Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies","volume":"45","author":"Sanyal","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.dld.2018.01.123","article-title":"Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis","volume":"50","author":"Song","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jvir.2010.05.009","article-title":"Effect of Transjugular Intrahepatic Portosystemic Shunt Placement on Renal Function: A 7-year, Single-center Experience","volume":"21","author":"Anderson","year":"2010","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI With mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hep.20559","article-title":"The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension","volume":"41","author":"Boyer","year":"2005","journal-title":"Hepatology"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Uriz","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jcrc.2015.05.006","article-title":"Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin","volume":"30","author":"Zhang","year":"2015","journal-title":"J. Crit. Care"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s11255-013-0527-7","article-title":"Management and outcome in hepatorenal syndrome: Need for renal replacement therapy in non-transplanted patients","volume":"46","author":"Sourianarayanane","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/liv.13389","article-title":"Renal replacement therapy in critically ill liver cirrhotic patients\u2014Outcome and clinical implications","volume":"37","author":"Staufer","year":"2017","journal-title":"Liver Int."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jamcollsurg.2007.04.006","article-title":"Early Renal Replacement Therapy in Patients with Postoperative Acute Liver Failure Associated with Acute Renal Failure: Effect on Postoperative Outcomes","volume":"205","author":"Wu","year":"2007","journal-title":"J. Am. Coll. Surg."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1603017","article-title":"Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit","volume":"375","author":"Gaudry","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2016.5828","article-title":"Effect of Early vs. Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients with Acute Kidney Injury","volume":"315","author":"Zarbock","year":"2016","journal-title":"JAMA"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Utako, P., Emyoo, T., Anothaisintawee, T., Yamashiki, N., Thakkinstian, A., and Sobhonslidsuk, A. (2018). Clinical Outcomes after Liver Transplantation for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis. Biomed. Res. Int., 2018.","DOI":"10.1155\/2018\/5362810"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007890-199502150-00010","article-title":"Impact of pretransplant renal function on survival after liver transplantation","volume":"59","author":"Gonwa","year":"1995","journal-title":"Transplantation"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/lt.22395","article-title":"Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1","volume":"17","author":"Boyer","year":"2011","journal-title":"Liver Transplant."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/hep.31529","article-title":"Response to Terlipressin and Albumin Is Associated with Improved Liver Transplant Outcomes in Patients with Hepatorenal Syndrome","volume":"73","author":"Piano","year":"2021","journal-title":"Hepatology"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11901-020-00527-9","article-title":"Selection for Liver Transplantation: Indications and Evaluation","volume":"19","author":"Mahmud","year":"2020","journal-title":"Curr. Hepatol. Rep."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"The model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic Renal Failure after Transplantation of a Nonrenal Organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.23384","article-title":"Impact of the etiology of acute kidney injury on outcomes following liver transplantation: Acute tubular necrosis versus hepatorenal syndrome","volume":"18","author":"Nadim","year":"2012","journal-title":"Liver Transplant."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","article-title":"The course of type 1 hepato-renal syndrome post liver transplantation","volume":"21","author":"Marik","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-199102000-00030","article-title":"Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome","volume":"51","author":"Gonwa","year":"1991","journal-title":"Transplantation"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/lt.24189","article-title":"Propensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction","volume":"22","author":"Sharma","year":"2016","journal-title":"Liver Transplant."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1526-0968.2001.00388.x","article-title":"Improvement of Multiple Organ Functions in Hepatorenal Syndrome During Albumin Dialysis with the Molecular Adsorbent Recirculating System","volume":"5","author":"Mitzner","year":"2001","journal-title":"Ther. Apher."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4254\/wjh.v8.i25.1075","article-title":"Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus","volume":"8","author":"Arab","year":"2016","journal-title":"World J. Hepatol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/lt.500060326","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2003","journal-title":"Liver Transplant."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial","volume":"57","author":"Nevens","year":"2013","journal-title":"Hepatology"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gut.2008.174615","article-title":"Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/jgh.15255","article-title":"Artificial liver support systems","volume":"36","author":"Tandon","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-2008-1073120","article-title":"Artificial and Bioartificial Liver Support","volume":"28","author":"McKenzie","year":"2008","journal-title":"Semin. Liver Dis."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1744-9987.2006.00354.x","article-title":"Review Article: Clinical Experience with Prometheus","volume":"10","author":"Rifai","year":"2006","journal-title":"Ther. Apher. Dial."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000086552","article-title":"The Prometheus \u00ae Device for Extracorporeal Support of Combined Liver and Renal Failure","volume":"23","author":"Rifai","year":"2005","journal-title":"Blood Purif."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","article-title":"Effects of Fractionated Plasma Separation and Adsorption on Survival in Patients with Acute-on-Chronic Liver Failure","volume":"142","author":"Kribben","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2019.04.007","article-title":"Therapeutic plasma exchange: Review of current indications","volume":"58","year":"2019","journal-title":"Transfus. Apher. Sci."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","article-title":"High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial","volume":"64","author":"Larsen","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1055\/s-0041-1730971","article-title":"Plasma Exchange in Acute and Acute on Chronic Liver Failure","volume":"41","author":"Maiwall","year":"2021","journal-title":"Semin. Liver. Dis."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1744-9987.13859","article-title":"Efficacy and safety of plasma diafiltration: Review of case reports and case series","volume":"27","author":"Zhang","year":"2023","journal-title":"Ther. Apher. Dial."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1744-9987.2007.00505.x","article-title":"A Case Report of Hepatorenal Syndrome Treated with Plasma Diafiltration (Selective Plasma Filtration with Dialysis)","volume":"11","author":"Nakae","year":"2007","journal-title":"Ther. Apher. Dial."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CCM.0000000000001380","article-title":"A Selective V1A Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*","volume":"44","author":"He","year":"2016","journal-title":"Crit. Care Med."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/hep.23893","article-title":"Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension","volume":"52","author":"Lens","year":"2010","journal-title":"Hepatology"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Snowdon, V.K., Lachlan, N.J., Hoy, A.M., Hadoke, P.W.F., Semple, S.I., Patel, D., Mungall, W., Kendall, T.J., Thomson, A., and Lennen, R.J. (2017). Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002248"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3889\/oamjms.2017.173","article-title":"Protective Effects of the Third Generation Vasodilatory \u0392eta-Blocker Nebivolol against D-Galactosamine-Induced Hepatorenal Syndrome in Rats","volume":"5","author":"Atwa","year":"2017","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semnephrol.2018.10.002","article-title":"Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome","volume":"39","author":"Amin","year":"2019","journal-title":"Semin. Nephrol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5604\/01.3001.0010.8660","article-title":"Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis","volume":"17","author":"Correa","year":"2018","journal-title":"Ann. Hepatol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","article-title":"Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients with Advanced Cirrhosis","volume":"138","author":"Lebrec","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/MEG.0000000000000967","article-title":"Long-term rifaximin therapy as a primary prevention of hepatorenal syndrome","volume":"29","author":"Ibrahim","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/apt.14275","article-title":"Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy","volume":"46","author":"Kang","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/j.1572-0241.2002.05791.x","article-title":"Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia","volume":"97","author":"Bauer","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1038\/ctg.2016.44","article-title":"Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition","volume":"7","author":"Kang","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/MEG.0000000000000940","article-title":"Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: A systematic review and meta-analysis","volume":"29","author":"Kamal","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1007\/s10620-016-4313-0","article-title":"Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis","volume":"61","author":"Dong","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"100159","DOI":"10.1016\/j.crphar.2023.100159","article-title":"Fucoidan alleviates the hepatorenal syndrome through inhibition organic solute transporter \u03b1\/\u03b2 to reduce bile acids reabsorption","volume":"5","author":"Zhao","year":"2023","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"553","DOI":"10.18097\/PBMC20176306553","article-title":"Evaluation of adjuvant effects of fucoidane from brown seaweed Fucus evanescens and its structural analogues for the strengthening vaccines effectiveness","volume":"63","author":"Kuznetsova","year":"2017","journal-title":"Biomeditsinskaya Khimiya"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"12579","DOI":"10.1007\/s11356-020-07854-w","article-title":"Effects of fucoidan on the hematic indicators and antioxidative responses of Nile tilapia (Oreochromis niloticus) fed diets contaminated with aflatoxin B1","volume":"27","author":"Dawood","year":"2020","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.biopha.2016.07.027","article-title":"Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells","volume":"83","author":"Cho","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cbi.2009.09.015","article-title":"Effect of fucoidan on aspirin-induced stomach ulceration in rats","volume":"183","author":"Choi","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ijbiomac.2018.10.129","article-title":"Primary structure and anticoagulant activity of fucoidan from the sea cucumber Holothuria polii","volume":"121","author":"Yacoubi","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Yu, W.-C., Huang, R.-Y., and Chou, T.-C. (2020). Oligo-Fucoidan Improves Diabetes-Induced Renal Fibrosis via Activation of Sirt-1, GLP-1R, and Nrf2\/HO-1: An In Vitro and In Vivo Study. Nutrients, 12.","DOI":"10.3390\/nu12103068"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"790937","DOI":"10.3389\/fphar.2022.790937","article-title":"Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte Colony\u2013Stimulating Factor Mobilizes CD34+ Cells and Improves Survival of Patients with Acute-on-Chronic Liver Failure","volume":"142","author":"Garg","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12072-017-9814-1","article-title":"Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: Increased survival and containment of liver damage","volume":"11","author":"Saha","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_255","first-page":"CD013532","article-title":"Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease","volume":"2023","author":"Colli","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_256","first-page":"474","article-title":"Hepatorenal syndrome: Current concepts related to diagnosis and management","volume":"15","year":"2016","journal-title":"Ann. Hepatol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis","volume":"133","author":"Navasa","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_258","first-page":"1","article-title":"Surgery and portal hypertension. Major Probl","volume":"1","author":"Child","year":"1964","journal-title":"Clin. Surg."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jceh.2015.12.003","article-title":"Dopamine and Furosemide for the Treatment of Hepatorenal Syndrome: A Reappraisal or Just Smoke and Mirrors?","volume":"5","author":"Piano","year":"2015","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/gastro\/goz043","article-title":"Pharmacological treatment of hepatorenal syndrome: A network meta-analysis","volume":"8","author":"Wang","year":"2020","journal-title":"Gastroenterol. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/24\/17469\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:38:40Z","timestamp":1760132320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/24\/17469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":260,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["ijms242417469"],"URL":"https:\/\/doi.org\/10.3390\/ijms242417469","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]}}}